15.306 articles found

Cardiovascular damage, arrhythmogenesis and overlapping Alzheimer and Parkinson’s diseases and TDP-43 pathology start in pediatric and young adult urban populations: Magnetic ultrafine particulate matter and industrial particles with motion behavior play a key role.

Calderón-Garcidueñas L, Cejudo-Ruiz FR, González-Maciel A, Reynoso-Robles R, Ramos-Morales A, Pérez-Guille BE, Soriano-Rosales DVM RE, Torres-Jardón R.

Environmental Research · 2025-01-01

Effect of saffron supplementation on Parkinson’s disease: a study protocol for a triple-blind randomised controlled clinical trial

Hajhashemy Z, Khorvash F, Bagherniya M, Askari G.

BMJ open · 2025-01-01

The impact of combined aerobic and resistance exercise on the prognosis of early Parkinson's disease patients.

Chen Y, Chen Y.

Technol Health Care · 2025-01-01

DOI: 10.3233/thc-240821PMID: 39177624

Clinical characteristics and phenoconversion in isolated REM sleep behavior disorder: a prospective single-center study in Korea, compared with Montreal cohort.

Byun JI, Sunwoo JS, Shin YW, Shin JW, Kim TJ, Jun JS, Shin JH, Kim HJ, Montplaisir J, Gagnon JF, Pelletier A, Delva A, Postuma RB, Jung KY.

J Clin Sleep Med · 2025-01-01

DOI: 10.5664/jcsm.11318PMID: 39177811

Translational evaluation of metabolic risk factors impacting DBS efficacy for PD-related sleep and depressive disorders: preclinical, prospective and cohort studies.

Yao L, Chen R, Zheng Z, Hatami M, Koc S, Wang X, Bai Y, Yao C, Lu G, Skutella T.

Int J Surg · 2025-01-01

DOI: 10.1097/js9.0000000000002081PMID: 39248306

T2 MRI visible perivascular spaces in Parkinson's disease: clinical significance and association with polysomnography measured sleep.

Meinhold L, Gennari AG, Baumann-Vogel H, Werth E, Schreiner SJ, Ineichen C, Baumann CR, O'Gorman Tuura R.

Sleep · 2025-01-01

DOI: 10.1093/sleep/zsae233PMID: 39377177

A Comprehensive Review on Repurposing the Nanocarriers for the Treatment of Parkinson's Disease: An Updated Patent and Clinical Trials.

Khan S, Haider MF.

CNS Neurol Disord Drug Targets · 2025-01-01

DOI: 10.2174/0118715273323074241001071645PMID: 39400019

Exploration of the Role of Vitamins in Preventing Neurodegenerative Diseases: Comprehensive Review on Preclinical and Clinical Findings.

Changkakoti L, Rajabalaya R, David SR, Balaraman AK, Sivasubramanian H, Mukherjee AK, Bala A.

Curr Neuropharmacol · 2025-01-01

DOI: 10.2174/011570159x327677240902105443PMID: 39572918

Impact of a Dynamic Orthosis on Manual Dexterity Among People With Parkinson's Disease: A Randomized Trial.

Jiménez-Barrios M, González-Bernal J, Santamaría-Peláez M, Collazo-Riobo C, Cubo E, Gabriel-Galán JMT, Matthews MJA, González-Santos J.

Am J Occup Ther · 2025-01-01

DOI: 10.5014/ajot.2025.050723PMID: 39607475

How well is the female population represented in clinical trials with infusion therapies for Parkinson's disease? A systematic review and metanalysis.

Smilowska K, Carvalho V, Szejko N, Costa J, Moro E, Antonini A.

Eur J Neurol · 2025-01-01

DOI: 10.1111/ene.70024PMID: 39757738

Domain-Specific Prediction of Clinical Progression in Parkinson's Disease Using the Mosaic Approach.

Tahedl M, Bogdahn U, Wimmer B, Hedderich DM, Kirschke JS, Zimmer C, Wiestler B.

Brain Behav · 2025-01-01

DOI: 10.1002/brb3.70289PMID: 39789902

Opicapone as adjunct to levodopa in treated Parkinson's disease without motor complications: A randomized clinical trial.

Ferreira JJ, Rascol O, Stocchi F, Antonini A, Moreira J, Castilla-Fernández G, Rocha JF, Holenz J, Poewe W, Epsilon Study investigators.

Eur J Neurol · 2025-01-01

DOI: 10.1111/ene.16420PMID: 39790009